Isotretinoin:: more adverse reactions

被引：0
|
作者：
Schmutz, J. -L.
Barbaud, A.
Trechot, P.
机构：
[1] Hop Fournier, Serv Dermatol, F-54035 Nancy, France
[2] Hop Cent, Serv Pharmacol, F-54035 Nancy, France
来源：
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE | 2007年 / 134卷 / 10期
关键词：
D O I：
10.1016/S0151-9638(07)92550-8
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：803 / 803
页数：1
相关论文
共 50 条
  • [1] ADVERSE REACTIONS TO ISOTRETINOIN
    BIGBY, M
    STERN, RS
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1988, 18 (03) : 543 - 552
  • [2] The evaluation of isotretinoin induced adverse drug reactions
    Entezari-Maleki, Taher
    Hadjibabaei, Molouk
    Salamzadeh, Jamshid
    Javadi, Mohammad Reza
    Shalviri, Gloria
    Gholami, Kheirollah
    AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY, 2011, 5 (16): : 1877 - 1881
  • [3] ADVERSE OCULAR REACTIONS POSSIBLY ASSOCIATED WITH ISOTRETINOIN
    FRAUNFELDER, FT
    LABRAICO, JM
    MEYER, SM
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1985, 100 (04) : 534 - 537
  • [4] Managing nonteratogenic adverse reactions to isotretinoin treatment for acne vulgaris
    Reilly, Bridget K.
    Ritsema, Tamara S.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2015, 28 (07): : 34 - 39
  • [5] MORE ADVERSE REACTIONS TO RIFAMPICIN
    GUTMAN, L
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1978, 4 (03) : 283 - 283
  • [6] Bevacizumab: not as good with more adverse reactions?
    Beaumont, Paul
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 39 (06): : 588 - 590
  • [7] Bevacizumab: not as good with more adverse reactions? Response
    Martin, Daniel F.
    Maguire, Maureen G.
    Fine, Stuart L.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 39 (07): : 718 - 720
  • [8] More adverse reactions with sargramostim than filgrastim
    Reactions Weekly, 2000, 817 (1) : 5 - 5
  • [9] Women experience more adverse reactions to HAART
    Reactions Weekly, 2002, 912 (1) : 4 - 4
  • [10] Is More Documentation Better for Adverse Drug Reactions?
    Parashar, Sonya
    Portnoy, Jay
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (10): : 2772 - 2773
12345